Correlation between antiphospholipid antibodies that recognize domain I of β2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5

The Antiphospholipid Syndrome

Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,524

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972

Acquired inhibitors of blood coagulation.

Feinstein, D., & Rapaport, S. I. (1972) · PubMed · Cited by 521

Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism

Rand, J. H., Wu, X.-X., Andree, H. A. M., Lockwood, C. J., Guller, S. M., Scher, J., & Harpel, P. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370303 · Cited by 519

IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosis

de Laat, B., Derksen, R. H. W. M., Urbanus, R. T., & de Groot, P. G. (2005) · Blood · doi:10.1182/blood-2004-09-3387 · Cited by 378

Progress in Hemostasis and Thrombosis.

(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-1-144_1 · Cited by 348

Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus

Horbach, D. A., van Oort, E., Donders, R. C. J. M., Derksen, R. H. W. M., & de Groot, P. G. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650686 · Cited by 246

Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphos pholipid antibodies and recurrent spontaneous abortion

Rand, J. H., Wu, X.-X., Guller, S. M., Gil, J., Guha, A., Scher, J., & Lockwood, C. J. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90403-0 · Cited by 229

Clustering of lipid-bound annexin V may explain its anticoagulant effect.

Andree, H. A. M., Stuart, M. C. A., Hermens, W. T., Reutelingsperger, C. P. M., Hemker, H. C., Frederik, P. M., & Willems, G. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37128-5 · Cited by 228

β2-glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome

de Laat, H. B., Derksen, R. H. W. M., Urbanus, R. T., Roest, M., & de Groot, P. G. (2004) · Blood · doi:10.1182/blood-2004-03-1107 · Cited by 219

Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′

Lutters, B. C. H., Derksen, R. H. W. M., Tekelenburg, W. L. H., Lenting, P. J., Arnout, J., & de Groot, P. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212655200 · Cited by 209

Growth of Protein 2-D Crystals on Supported Planar Lipid Bilayers Imagedin Situby AFM

Reviakine, I., Bergsma‐Schutter, W., & Brisson, A. R. (1998) · Journal of Structural Biology · doi:10.1006/jsbi.1998.4003 · Cited by 194

Immunological specificity and mechanism of action of IgG lupus anticoagulants

Pengo, V., Thiagarajan, P., Shapiro, S., & Heine, M. (1987) · Blood · doi:10.1182/blood.v70.1.69.69 · Cited by 194

Placental anticoagulant proteins: isolation and comparative characterization of four members of the lipocortin family

Tait, J. F., Sakata, M., McMullen, B. A., Miao, C. H., Funakoshi, T., Hendrickson, L. E., & Fujikawa, K. (1988) · Biochemistry · doi:10.1021/bi00417a011 · Cited by 180

Human Monoclonal Antiphospholipid Antibodies Disrupt the Annexin A5 Anticoagulant Crystal Shield on Phospholipid Bilayers

Rand, J. H., Wu, X.-X., Quinn, A. S., Chen, P. P., McCrae, K. R., Bovill, E. G., & Taatjes, D. J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63479-7 · Cited by 161

Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.

Gris, J., Quéré, I., Sanmarco, M., Boutiere, B., Mercier, É., Amiral, J., Hubert, A., Ripart-Neveu, S., Hoffet, M., Tailland, M.-L., et al. (2000) · PubMed · Cited by 135

NFκB is an Essential Intermediate in the Activation of Endothelial Cells by Anti-β2-Glycoprotein 1 Antibodies

Dunoyer-Geindre, S., de Moerloose, P., Rochemonteix, B. G.-D., Reber, G., & Kruithof, E. K. O. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613313 · Cited by 125

Antiphospholipid and Antiprotein Syndromes in Non-thrombotic, Non-autoimmune Women with Unexplained Recurrent Primary Early Foetal Loss

Quéré, I., Sanmarco, M., Boutiere, B., Mercier, É., Amiral, J., Hubert, A.-M., Ripart-Neveu, S., Hoffet, M., Tailland, M.-L., Rousseau, O., et al. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614001 · Cited by 112

Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi

Rand, J. H., Wu, X.-X., Guller, S. M., Scher, J., Andree, H. A. M., & Lockwood, C. J. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70294-1 · Cited by 108

Endothelial cell activation by antiphospholipid antibodies

Meroni, P. L., Raschi, E., Testoni, C., & Borghi, M. O. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.02.015 · Cited by 105

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome

Rand, J. H. (2004) · Blood · doi:10.1182/blood-2004-01-0203 · Cited by 104

Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation

Vogt, E., Ng, A., & Rote, N. S. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70302-8 · Cited by 102

Decreased Binding of Annexin V to Endothelial Cells

Cederholm, A., Svenungsson, E., Jensen‐Urstad, K., Trollmo, C., Ulfgren, A., Swedenborg, J., Fei, G., & Frostegård, J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000150415.18759.36 · Cited by 92

Dimers of β2-Glycoprotein I Mimic thein Vitro Effects of β2-Glycoprotein I-Anti-β2-glycoprotein I Antibody Complexes

Lutters, B. C. H., Meijers, J. C. M., Derksen, R. H. W. M., Arnout, J., & de Groot, P. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008224200 · Cited by 73

Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding.

George, J., Gilburd, B., Hojnik, M., Levy, Y. M., Langevitz, P., Matsuura, E., Koike, T., & Shoenfeld, Y. (1998) · PubMed · Cited by 72

Competition of Annexin V and Anticardiolipin Antibodies for Binding to Phosphatidylserine Containing Membranes

Willems, G. M., Janssen, M. P., Comfurius, P., Galli, M., Zwaal, R. F. A., & Bevers, E. M. (2000) · Biochemistry · doi:10.1021/bi9921081 · Cited by 58

Target Recognition of β2-Glycoprotein I (β2GPI)-Dependent Anticardiolipin Antibodies: Evidence for Involvement of the Fourth Domain of β2GPI in Antibody Binding

George, J., Gilburd, B., Hojnik, M., Levy, Y. M., Langevitz, P., Matsuura, E., Koike, T., & Shoenfeld, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3917 · Cited by 58

Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.

Chopra, N., Koren, S., Greer, W. L., Fortin, P. R., Rauch, J., Fortin, I., Senécal, J., Docherty, P., & Hanly, J. G. (2002) · PubMed · Cited by 50

Antiphospholipid antibody syndrome: Rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies

Tomer, A. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.121551 · Cited by 26

Procoagulant Effect of Anti–β2-Glycoprotein I Antibodies With Lupus Anticoagulant Activity

Pengo, V., Brocco, T., Biasiolo, A., Rampazzo, P., Carraro, P., & Zamarchi, R. (1999) · Blood · doi:10.1182/blood.v94.11.3814 · Cited by 23

The influence of anti‐endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells

Patterson, A. M., Ford, I., Graham, A., Booth, N. A., & Greaves, M. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.05994.x · Cited by 19

Untitled work

Wilson (1999) · doi:10.1002/1529-0131(199907)42:7

The Pathogenesis of the Antiphospholipid Syndrome

Giannakopoulos, B., & Krilis, S. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1112830 · Cited by 687

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

Bertolaccini, M. L., Amengual, O., Andreoli, L., Atsumi, T., Chighizola, C. B., Forastiero, R., de Groot, P., Lakos, G., Lambert, M., Meroni, P., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.05.001 · Cited by 266

β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome

Ağar, Ç., OS, G. M. A. V., Mörgelin, M., Sprenger, R. R., Marquart, J. A., Urbanus, R. T., Derksen, R. H. W. M., Meijers, J. C. M., & de Groot, P. G. (2010) · Blood · doi:10.1182/blood-2009-12-260976 · Cited by 262

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

Rand, J. H., Wu, X.-X., Quinn, A. S., Ashton, A. W., Chen, P. P., Hathcock, J. J., Andree, H. A. M., & Taatjes, D. J. (2010) · Blood · doi:10.1182/blood-2009-04-213520 · Cited by 253

Antiphospholipid antibodies promote leukocyte–endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2

Ramesh, S., Morrell, C. N., Tarango, C., Thomas, G. D., Yuhanna, I. S., Girardi, G., Herz, J., Urbanus, R. T., de Groot, P. G., Thorpe, P. E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39828 · Cited by 195

Pathological Anti-β2-Glycoprotein I Antibodies Disrupt the Anticoagulant Activity of Annexin A5: A Possible Explanation for the Lupus Anticoagulant Paradox.

de Laat, B., Wu, X.-X., van Lummel, M., Derksen, R. H. W. M., de Groot, P. G., & Rand, J. H. (2005) · Blood · doi:10.1182/blood.v106.11.135.135

Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C

de Laat, B., Eckmann, C. M., van Schagen, M., Meijer, A. B., Mertens, K., & van Mourik, J. A. (2008) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32830f1b85 · Cited by 45

Lupus Anticoagulant Activity Is Frequently Dependent on the Presence of β2-Glycoprotein I

Oostin, J. D., Derksen, R. H. W. M., Entjes, H. T. I., Bouma, B. N., & de Groot, P. G. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648480 · Cited by 143

Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.

Oosting, J. D., Derksen, R. H. W. M., Entjes, H. T. I., Bouma, B. N., & de Groot, P. G. (1992) · PubMed · Cited by 174

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats

Durigutto, P., Grossi, C., Borghi, M. O., Macor, P., Pregnolato, F., Raschi, E., Myers, M. P., de Groot, P. G., Meroni, P. L., & Tedesco, F. (2018) · Haematologica · doi:10.3324/haematol.2018.198119 · Cited by 56